Pfm Health Sciences, LP Vertex Pharmaceuticals Inc Transaction History
Pfm Health Sciences, LP
- $1.95 Billion
- Q2 2024
A detailed history of Pfm Health Sciences, LP transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Pfm Health Sciences, LP holds 148,852 shares of VRTX stock, worth $76.9 Million. This represents 3.58% of its overall portfolio holdings.
Number of Shares
148,852
Previous 148,852
-0.0%
Holding current value
$76.9 Million
Previous $62.2 Million
12.13%
% of portfolio
3.58%
Previous 3.07%
Shares
7 transactions
Others Institutions Holding VRTX
# of Institutions
1,717Shares Held
226MCall Options Held
1.19MPut Options Held
1.56M-
Capital World Investors Los Angeles, CA26.7MShares$13.8 Billion2.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA23MShares$11.9 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$11 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.7MShares$6.06 Billion0.24% of portfolio
-
Capital Research Global Investors Los Angeles, CA8.54MShares$4.41 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $133B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...